mGlu4R,mGlu7R和mGlu8R全质调制用于治疗急性和慢性神经退行性疾病
Helena Domin1, Grzegorz Burnat2
1Maj Institute of Pharmacology, Department of Neurobiology, Polish Academy of Sciences, Smętna 12, Kraków, 31-343, Poland. domin@if-pan.krakow.pl.
Pharmacological reports : PR
|September 30, 2024
概括
针对元类谷氨基质受体 (mGluRs) 的神经保护策略在中枢神经系统疾病方面表现有前途. 第三组mGluRs,特别是mGlu4,mGlu7和mGlu8,在临床前模型中表现出神经保护作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 神经保护旨在预防中枢神经系统 (CNS) 疾病中的神经元损伤,如中风,阿尔茨海默氏症和帕金森病.
- 过度的谷氨酸 (Glu) 传输会导致兴奋毒性,这是中枢神经系统疾病的关键病理机制.
- 甲基胺基质受体 (mGluRs) 是一种G蛋白结合受体 (GPCRs) 的类别,是调节Glu传播的潜在治疗标.
研究的目的:
- 审查针对中枢神经系统疾病的第三组mGluRs的神经保护潜力.
- 探索mGluR亚型在治疗干预中的作用,包括同型和异型化.
- 在临床前模型中总结目前关于向III组mGluRs的配体的知识.
主要方法:
- 临床前细胞 (体外) 和动物 (体内) 模型的审查.
- 对研究III组mGluRs的配体的研究分析.
- 检查mGluR结构,功能和亚型相互作用.
主要成果:
- 激活mGlu4或mGlu7受体的化合物在实验性缺血模型中显示出保护作用.
- 针对特定的mGluR亚型的异性联体突出显示了III组mGluR作为有前途的治疗标.
- 第三组mGluRs与帕金森病 (mGlu4R),TBI (mGlu7R) 和MS (mGlu8R) 的神经保护有关.
结论:
- 目标组III mGluRs为各种神经和精神疾病提供了一个有前途的治疗策略.
- 了解mGluR相互作用和全调节对于开发有效的神经保护剂至关重要.
- 对特定的mGluR亚型的进一步研究可能会导致对衰弱的中枢神经系统疾病的新疗法.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Ligand-gated Ion Channels
12.2K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
106
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
106
Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
Cholinergic Receptors: Muscarinic
2.0K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.0K


